On April 2019, 4, Hyogo College of Medicine and Shimadzu Corporation signed a "Comprehensive Joint Research Agreement".Aiming to develop an early diagnosis system for cancer, we have set up an industry-academia collaboration course "Disease Omics Analysis Course".
The "Disease Omics Analysis Course" is held by Hyogo College of Medicine, which conducts cutting-edge research, and Shimadzu Corporation, which excels in analytical technology and equipment. The purpose is to develop testing methods and early diagnosis systems for major cancer types.
A research base is set up at Hyogo College of Medicine, and blood samples of healthy people and cancer patients are collected in collaboration with Hyogo College of Medicine Hospital and Health Igaku Clinic within the same corporation.We will apply these samples to Shimadzu's mass spectrometer and proceed with research using "disease omics analysis technology."
Omics is a field that comprehensively studies the entire molecules (DNA, mRNA, proteins, metabolites, etc.) that make up an organism at various levels.Disease omics analysis has been used as a useful research method in the field of life science such as regenerative medicine and drug development.In this course, we will focus on changes in the omics hierarchy in each disease, gain new knowledge of diseases based on metabolic disorders in the body, and utilize them for cancer diagnosis and treatment.
Currently, we are collecting blood samples of healthy people at the Health Igaku Clinic and blood samples of patients with pancreatic cancer, colon cancer, and breast cancer at each department of Hyogo College of Medicine Hospital.In the future, while building a system to receive samples from other types of cancer patients, we will compare the amount of metabolites in the blood samples of healthy subjects and patients, and biomarkers that will lead to early detection of multiple types of cancer. * Search and aim to implement an early cancer screening method.
* Biomarkers are substances in the body that reflect the presence or absence of diseases and the degree of progression (physiological state), and are indicators for quantitatively grasping biological changes in the body.
